Search research articles
Contact Us
Filters
Showing results (71-80 of 142) with videos related to
Page
of 15
Sort By:
Cancer
|
September 1, 1990
Comparability of EORTC and DAPROCA studies in advanced prostatic cancer
S Suciu, R Sylvester, P Iversen, et al.
Cancer
|
December 15, 1993
Comparability of prostate trials
S Suciu, R Sylvester, P Iversen, et al.
The Journal of Urology
|
April 1, 1983
The relevance of minimum urethral resistance in prostatism
R Bruskewitz, K M Jensen, P Iversen, et al.
The Journal of Antimicrobial Chemotherapy
|
March 1, 1982
Tetroxoprim-sulphadiazine distribution in canine prostate
O S Nielsen, P Iversen, H Vergin, et al.
The Journal of Urology
|
January 23, 1999
Mortality of patients with clinically localized prostate cancer treated with observation for 10 years or longer: a population based registry study
K Brasso, S Friis, K Juel, et al.
Journal of Chromatography
|
October 26, 1988
Chromatographic and spectral investigations on the in vivo metabolites of 6-nitrobenzo[a]pyrene
C Raha, D Williamson, P Thakran, et al.
The Journal of Urology
|
March 29, 2000
The need for hospital care of patients with clinically localized prostate cancer managed by noncurative intent: a population based registry study
K Brasso, S Friis, K Juel, et al.
Ugeskrift for Laeger
|
October 23, 2001
[Morbidity among patients with clinically localized prostatic cancer. A registry-based case-control study]
K Brasso, S Friis, K Juel, et al.
The Prostate. Supplement
|
January 1, 1992
Local staging of prostate cancer with transrectal ultrasound: a literature review
T Lorentzen, H Nerstrom, P Iversen, et al.
Cancer
|
September 1, 1990
Zoladex and flutamide versus orchiectomy in the treatment of advanced prostatic cancer. A combined analysis of two European studies, EORTC 30853 and DAPROCA 86
P Iversen, S Suciu, R Sylvester, et al.
Page
of 15
Search research articles
Search
Showing results (71-80 of 142) with videos related to
Sort By:
Page
of 15
Cancer
|
September 1, 1990
Comparability of EORTC and DAPROCA studies in advanced prostatic cancer
S Suciu, R Sylvester, P Iversen, et al.
Cancer
|
December 15, 1993
Comparability of prostate trials
S Suciu, R Sylvester, P Iversen, et al.
The Journal of Urology
|
April 1, 1983
The relevance of minimum urethral resistance in prostatism
R Bruskewitz, K M Jensen, P Iversen, et al.
The Journal of Antimicrobial Chemotherapy
|
March 1, 1982
Tetroxoprim-sulphadiazine distribution in canine prostate
O S Nielsen, P Iversen, H Vergin, et al.
The Journal of Urology
|
January 23, 1999
Mortality of patients with clinically localized prostate cancer treated with observation for 10 years or longer: a population based registry study
K Brasso, S Friis, K Juel, et al.
Journal of Chromatography
|
October 26, 1988
Chromatographic and spectral investigations on the in vivo metabolites of 6-nitrobenzo[a]pyrene
C Raha, D Williamson, P Thakran, et al.
The Journal of Urology
|
March 29, 2000
The need for hospital care of patients with clinically localized prostate cancer managed by noncurative intent: a population based registry study
K Brasso, S Friis, K Juel, et al.
Ugeskrift for Laeger
|
October 23, 2001
[Morbidity among patients with clinically localized prostatic cancer. A registry-based case-control study]
K Brasso, S Friis, K Juel, et al.
The Prostate. Supplement
|
January 1, 1992
Local staging of prostate cancer with transrectal ultrasound: a literature review
T Lorentzen, H Nerstrom, P Iversen, et al.
Cancer
|
September 1, 1990
Zoladex and flutamide versus orchiectomy in the treatment of advanced prostatic cancer. A combined analysis of two European studies, EORTC 30853 and DAPROCA 86
P Iversen, S Suciu, R Sylvester, et al.
Page
of 15